USD 0.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2770.00 | -3.29 Million | -1.48 Million | -2.29 Million | -1.97 Million | -2.58 Million |
Net Income | -9647.00 | -2.55 Million | -1.75 Million | -2.84 Million | -2.41 Million | -3.15 Million |
Depreciation & Amortization | - | - | 277.00 | 5329.84 | 6230.51 | 4775.74 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 105 Thousand | 485 Thousand | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 6877.00 | -739.31 Thousand | 278.76 Thousand | 543.15 Thousand | 438.21 Thousand | 695.34 Thousand |
Investing Cash Flow | 34.93 Million | -186 Thousand | 6.03 Million | -5.17 Million | -500 Thousand | -2.05 Million |
Investments in PPE | - | -327 Thousand | -426 Thousand | -564 Thousand | -501 Thousand | -2.05 Million |
Acquisitions | - | 138.43 Thousand | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | 141 Thousand | 6.13 Million | - | - | - |
Other Investing Activities | 34.93 Million | -138.43 Thousand | 327 Thousand | -4.61 Million | 1000.00 | 1000.00 |
Financing Cash Flow | -31.44 Million | 345 Thousand | -352.73 Thousand | 9.89 Million | 1.5 Million | 3.45 Million |
Debt repayment | - | - | - | -720 Thousand | -835 Thousand | -3.29 Million |
Dividends payments | -32.2 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 345 Thousand | - | 10 Million | 1.84 Million | - |
Other Financing Activities | - | 345.00 | - | 607 Thousand | 492 Thousand | 3.45 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 3.62 Million | 6.68 Million | 2.79 Million | 398 Thousand | 1.25 Million | 2.55 Million |
Cash at end of period | 4.38 Million | 3.48 Million | 6.68 Million | 2.79 Million | 398 Thousand | 1.25 Million |
Capital Expenditure | - | -327 Thousand | -426 Thousand | -564 Thousand | -501 Thousand | -2.05 Million |
Effect of forex changes on cash | 46 Thousand | -61.01 Thousand | -313 Thousand | -125 Thousand | 41 Thousand | -116 Thousand |
Net cash flow / Change in cash | 760 Thousand | -3.19 Million | 3.89 Million | 2.39 Million | -859 Thousand | -1.29 Million |
Free Cash Flow | -2770.00 | -3.62 Million | -1.9 Million | -2.85 Million | -2.47 Million | -4.63 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -8216.72 | -8202.20 | -211 Thousand | -9647.00 | -211.00 | -2.02 Million |
Depreciation & Amortization | 5056.44 | 5047.51 | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -262.93 Thousand | -262.47 Thousand | - | - | - | - |
Other non-cash items | -29.7 Thousand | -29.65 Thousand | -109.5 Thousand | 6877.00 | -109.50 | -164.68 Thousand |
Investing Cash Flow | 1.48 Million | 1.48 Million | 465.5 Thousand | 34.93 Million | 465.50 | 34.99 Million |
Investments in PPE | -4424.39 | -4416.57 | - | - | - | - |
Acquisitions | 1.48 Million | 1.48 Million | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | 36.02 Million |
Other Investing Activities | -0.61 | 0.57 | 465.5 Thousand | 34.93 Million | 465.50 | -1.02 Million |
Financing Cash Flow | 64.46 Thousand | 64.35 Thousand | -1.07 Million | -31.44 Million | -1077.00 | -30.15 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -1.07 Million | -32.2 Million | -1077.00 | -30.15 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 128.95 Thousand | - | - | - | - | - |
Other Financing Activities | 64.46 Thousand | 64.35 Thousand | - | - | - | - |
Accounts receivables | -262.93 Thousand | -262.47 Thousand | - | - | - | - |
Accounts payables | 360.32 Thousand | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -56.89 Thousand | - | - | - | - | - |
Cash at beginning of period | 4.37 Million | - | 6.3 Million | 3.62 Million | - | 3.5 Million |
Cash at end of period | 2.35 Million | 1.17 Million | 4.37 Million | 4.38 Million | -896.00 | 6.3 Million |
Capital Expenditure | -4424.39 | -4416.57 | - | - | - | - |
Effect of forex changes on cash | -77.11 Thousand | -76.97 Thousand | 36 Thousand | 46 Thousand | 36.00 | 34.50 |
Net cash flow / Change in cash | -2.02 Million | 1.17 Million | -1.92 Million | 760 Thousand | -896.00 | 2.8 Million |
Free Cash Flow | -300.22 Thousand | -299.69 Thousand | -320.5 Thousand | -2770.00 | -320.50 | -2.19 Million |
000949
000917
MEDINOV
002712
SWASTIKA
EGG